₹ 1,871.00
-10.60 (-0.56%)
NSE
B
Beta Drugs
₹ 1,871.00
NSE
Beta Drugs Fundamentals
Company Valuation
Market Cap (₹ Cr.)
2,081
PE Ratio
39.20
PB Ratio
4.78
Dividend Yield
-
ROE
16.95%
ROCE
17.98%
Book Value (₹)
393.57
Face Value (₹)
10.00
Analyse BETA with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Dec 2025 | Mar 2026 | May 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 64.90% | 66.73% | 59.10% | 59.10% | 58.91% |
| Domestic Institutional Investors (DII) | 1.89% | 0.29% | 6.01% | 6.23% | 6.45% |
| Foreign Institutional Investors (FII) | 1.14% | 0.90% | 2.95% | 1.02% | 1.37% |
| Public Investors | 21.78% | 21.81% | 22.72% | 24.30% | 22.00% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
BETA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Microcap
BSE Scrip Code
0
NSE Scrip Name
BETA
ISIN
INE351Y01019

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






